The reaction between binding intrinsic factor antibody and intrinsic factor-vitamin B12 complex has been studied. Initially in the zone of antibody excess, the relationship between the amount of antigen present and the amount of antigen-antibody complex adsorbed onto zirconium phosphate gel was linear. With increasing amounts of antigen, the curve departed from linearity and reached a plateau. The linear portion of the reaction forms the basis of a simple and reproducible assay for quantitating intrinsic factor to which vitamin B12 has already been bound. The assay provides a method for studying the fate of intrinsic factor-vitamin B12 complex during digestion and absorption. In two normal subjects given radioactive vitamin B12 orally, aspiration of ileal contents showed that only 50 to 70 % of the radioactivity was bound to intrinsic factor at that level.
The study of the physiology of vitamin B12 absorption has been hampered by the lack of a simple assay for human intrinsic factor-vitamin B12 complex. The activity of human intrinsic factor-radioactive vitamin B12 complex can be measured in vivo in patients with pernicious anaemia (Heinle, Welch, Scharf, Meacham, and Prusoff, 1952; Schilling, 1953; Glass, Boyd, Gellin, and Stephanson, 1954; Baker and Mollin, 1955) . However, this requires the cooperation of patients with pernicious anaemia, is time consuming, and comparatively insensitive. Human intrinsic factor-vitamin B12 complex can also be estimated in vitro by techniques employing ileal segments, everted ileal sacs, or small intestinal homogenates (Wilson and Wiseman, 1954; Wolff and Nabet, 1961; Sullivan, Herbert, and Castle, 1962; Boass and Wilson, 1963; Castro-Curel and Glass, 1963) . These techniques have the disadvantage that they are specialized and difficult to apply to large numbers of samples.
The recognition of two types of intrinsic factor antibodies, the blocking antibody which prevents the combination of vitamin B12 with intrinsic factor, and the binding antibody which unites either with intrinsic factor or intrinsic factor-vitamin B12 complex (Garrido-Pinson, Turner, Crookston, Samloff, Miller, and Segal, 1966) , has made possible the development of specific in vitro intrinsic factor assays.
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A variety of techniques employing the blocking antibody have been described, but these are only applicable to free intrinsic factor and cannot measure intrinsic factor already bound to vitamin B12 (Ardeman and Chanarin, 1963; Gottlieb, Lau, Wasserman, and Herbert, 1965; Hansen, Miller, and Tan, 1966) . The binding antibody, because it combines with the intrinsic factor-vitamin B12 complex, is potentially capable of quantitating the latter. To date, the only ways of measuring intrinsic factorvitamin B12 complex, employing the binding antibody, have been the electrophoretic retention method (Jeffries and Sleisenger, 1963; Bardhan, Wangel, and Callender, 1967) and the competitive inhibition of the antibody using sodium sulphate precipitation (Rothenberg, 1966) . These are rather complicated techniques and do not appear to have gained wide acceptance. Moreover, in practice, these techniques have only been advocated as methods for measuring intrinsic factor activity, and their potential in quantitating the intrinsic factor-vitamin B12 complex has not been exploited.
This communication reports studies on the combination of the binding antibody with intrinsic factor-vitamin B12 complex and the use of this reaction in a simple and sensitive in-vitro assay for intrinsic factor-vitamin B12 complex. The assay has been employed in a preliminary study of the fate of intrinsic factor-vitamin B12 complex in the intestine. 320 A simple assay of intrinsic factor-vitamin B12 comp ex employing the binding intrinsic factor antibody 321
Materials and Methods
The technique is based on the fact that zirconium gel adsorbs protein complexes at or below their isoelectric point. The vitamin B12 binders in gastric juice, including intrinsic factor, are quantitatively adsorbed onto the gel at pH 5 0, but at pH above 5 5 the negative charge of the intrinsic factor and other gastric juice binders increases and they are not adsorbed onto the gel . When the binding type antibody is attached to the intrinsic factor-vitamin B12 complex, the isoelectric point changes and it is adsorbed onto the gel at pH 6-25 (Jacob, Hansen, and Miller, 1966 Sera containing the binding and blocking antibody were obtained from four patients with pernicious anaemia. The titre of the antibodies in these sera was measured by zirconium gel assay Jacob et al, 1966) . Control sera were obtained from healthy adults with no demonstrable intrinsic factor antibodies. To prevent radioactive vitamin B12 from binding to transcobalamin II in the serum and being adsorbed to the gel (Hansen, Tan, and Jacob, 1967) , the vitamin B12 binding sites of the antibody sera and the control sera were saturated by adding excess non-radioactive vitamin B12 (5 ng/ml). When the sera were used as a source of blocking antibody, the unbound vitamin B12 was removed by albumincoated charcoal prepared as described by Gottlieb et al (1965) . The removal of excess unlabelled vitamin B12 was unnecessary when the serum was used as a source of binding antibody because the serum was added to the system after radioactive vitamin B12 was combined with intrinsic factor.
Gastric juices were obtained from healthy adult volunteers and patients with pernicious anaemia. The fasting juice was discarded. An intramuscular injection of pentagastrin (6 ,ug/kg body weight) was given and the juice aspirated at 15, 30, and 45 minutes thereafter. The juice was immediately filtered through glass wool, thepH adjusted to 10-0 with 1N NaOH to inactivate the pepsin and 30 minutes later brought back to 7/4 by the addition of IN HCI. The juice was divided into aliquots and stored at -200C until further use.
The intrinsic factor content of each sample of gastric juice was estimated by the use of the binding antibody in the assay described below and by the blocking antibody employing either albumin-coated charcoal (Gottlieb et al, 1965) or zirconium gel at pH 5 0 .
Results

OBSERVATIONS ON THE COMBINATION OF BINDING ANTIBODY WITH INTRINSIC FACTOR-VITAMIN B12 COMPLEX
To determine whether the combination of the binding antibody with intrinsic factor-vitamin B12 complex could be used for assay of the complex, a detailed study of the reaction was undertaken using a fixed amount of antibody and increasing amounts of the complex. Radioactive vitamin B12 was added to gastric juice in excess of its total binding capacity to saturate all available intrinsic factor molecules. The juice was diluted 1 in 10 with 0-15M NaCI and duplicate amounts ranging from 0 05 to 1I0 ml were added to two sets of test tubes. To one set, 0-1 ml of serum containing 6-5 ng units of the binding antibody was added, and to the other set 0-1 ml of control serum was added. Ten ml of zirconium gel (pH 6 25) was then added to each tube. The tubes were mixed in a vortex mixer, centrifuged at 1000 g for five min and the supernatants discarded. The gel was washed three times with 15 ml of 0-1M am-0 0.5 1. VOLUME OF DILUIED GASTRIC JUICE ml. A simple assay ofintrinsic factor-vitamin B12 complex employing the binding intrinsic factor antibody 323 days. The values ranged from 145 to 162 ng units/ml with a coefficient of variation of 3-8 % (Table II) . body . The results are shown in Figure 3 . There is good correlation between the two assays (r = 0 99) although the binding antibody method gives a slightly lower value (approximately 5%) than the blocking antibody method. The present assay was also compared with the albumin-coated charcoal assay (Gottlieb et al, 1965) (Fig. 4) . Again there is good correlation between the results of the two assays (r = 0-99), although the binding antibody method gives values about 12% lower.
USE OF ASSAY IN MEASURING INTRINSIC FACTOR-57CO VITAMIN B12 IN INTESTINAL JUICE
Two volunteers, with normal vitamin B12 absorption and normal secretion of intrinsic factor, were intubated orally with a fine radioopaque polyvinyl tube. When the distal end of the tube was in the upper ileum, a 1 ,tg dose of 57Co vitamin B12 (1 Juc) was given by mouth. Commencing 45 minutes later, ileal juice was aspirated at intervals with a syringe and the radioactivity of the aspirates monitored. The two specimens containing the most radioactivity were centrifuged at 4°C at 10 000 g for one hour andc the supernatants removed. None of the sediments contained any significant amounts of radioactivityThe radioactivity in the supernatants was present in Table III Results of study of vitamin B12 binding on ileal juice obtained after feeding radioactive vitamin BI2
at least three forms: 'unbound' radioactivity which was measured and removed by treatment with albumin-coated charcoal; intrinsic factor-57Co vitamin B12 complex which was measured by the present assay; and 57Co vitamin B12 bound to unknown non-intrinsic factor binders, which was estimated by subtracting the other two quantities from the total amount of radioactivity in the supernatants. Table III shows the results of this study on two specimens of ileal juice from each of two patients and Fig. 5 the results of the intrinsic factor-vitamin B12 complex assay on one of the specimens. The intrinsic factor content of gastric juices measured by the present assay tends to be a little lower than the results obtained using the two assays employing the blocking type antibody although there is an excellent correlation between the assays. Bardhan et al (1967) also noticed that the results of the charcoal assay using the blocking antibody were higher than their results using the binding antibody with the electrophoretic retention technique. Schade, Feick, Imrie, and Schilling '1967) protein in the system, produced alterations in the estimation of total vitamin B12 binding and in the apparent intrinsic factor content when blocking antibody was added to the system. There is no evidence as to which of the assays gives a better measure of the physiological activity of intrinsic factor in promoting vitamin B12 absorption. Any of the three assays appears to be satisfactory for the estimation of intrinsic factor in routine clinical practice.
The present assay has been shown to be simple and reproducible and to give a good measure of intrinsic factor. In addition, it has the great advantage that it can be used to measure intrinsic factor to which radioactive vitamin B12 has already been bound. It is therefore capable of being used to quantitate accurately intrinsic factor-vitamin B12 complex such as is sometimes used in the diagnosis of pernicious anaemia and other vitamin B12 malabsorptive states.
The most important aspect of the present assay is its potential for the study of the physiology and pathology of vitamin B12 absorption. The preliminary results of the study of the fate of intrinsic factor-vitamin B12 complex in two subjects demonstrate this application of the assay. The findings are of interest in that only 50 to 70% of administered radioactivity recovered from the ileum was bound to intrinsic factor. This percentage was the same in each of the two specimens obtained from each patient, even though in patient A the second specimen was obtained one hour after the first. This may well explain why in normal subjects a test dose of radioactive vitamin B12 is never completely absorbed. Further studies are in progress.
